Spravato - a first of its kind nasal spray - is an esketemine, for adults with "treatment resistant" depression. After taking Spravato patients are to remain on site for an observation period. During this time, they can take advantage of one of our Guided VR demonstrations - allowing users to see exactly how SPRAVATO is working inside their brain after being administered.